| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 9.53× | 9.53× | 1.52× | 0.09× | 0.00× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.01× | 0.01× | 0.01× | 0.01× | 0.01× | ||
| 0.87× | 0.87× | 1.34× | 0.73× | 0.78× | ||
| 0.65× | 0.65× | 0.97× | 0.55× | 0.59× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 0.00 | 0.09 | 1.52 | 9.53 | 9.53 | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Cash Conversion (CFO/Net Income) | 0.78 | 0.73 | 1.34 | 0.87 | 0.87 | |
| CFO/EBITDA | 0.59 | 0.55 | 0.97 | 0.65 | 0.65 |